"You attempt to wriggle out of it by claiming that your post was about finance and capital. No it wasn't. It was about my style of communication with MSB."
OK. If that's the way it came across to you, I apologise on the basis of it not being my intention to come across the way you perceived it.
My line of questioning to you, who I consider to be - as I said - a reasonably cogent and lucid thinker (one of the few that I encounter who is holder) - was intended to relate to the way the company has dealt with the issue of funding (both in the way it has gone about it, and the way it has failed to articulate it to the market subsequent to the Teva announcement).
So I'll ask again, a question that is specific to budgeted expenditure and the financing thereof:
How do you, as a shareholder, feel about the company's managers telling you that the matter of how much cash the business needs, and over what time frame, and where such cash will be sourced, is not one for which it is appropriate to divulge details to the owners of the business?
I'm really trying to reconcile why people focus on just about every other aspect of the company, other than the thing that is THE most important, and has been for some time now (not just after the Teva shock), namely, how the business funds itself.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)